1-2 of 2
Keywords: Metabolic dysfunction-associated steatotic liver disease
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Weight-Loss Plateau during Lifestyle Intervention Predicts Treatment Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity

Open Access
Subject Area:
Nutrition and Dietetics
Ling Luo, Junzhao Ye, Ting Zhou, Zhi Dong, Shiting Feng, Wei Wang, Shuyu Zhuo, Bihui Zhong
Journal: Obesity Facts
Obes Facts (2025)
https://doi.org/10.1159/000543818
Published Online: 06 March 2025
...Ling Luo; Junzhao Ye; Ting Zhou; Zhi Dong; Shiting Feng; Wei Wang; Shuyu Zhuo; Bihui Zhong Introduction: Whether the weight-loss plateau and its values differ in obesity with or without metabolic dysfunction-associated steatotic liver disease (MASLD) undergoing continuous lifestyle intervention...
View articletitled, Weight-Loss Plateau during Lifestyle Intervention Predicts Treatment Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity
Open the PDF for Weight-Loss Plateau during Lifestyle Intervention Predicts Treatment Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity in another window
Journal Articles

Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver ® ) Diagnoses

Open Access
Subject Area:
Nutrition and Dietetics
Èlia Navarro-Masip, Nuria Mestres Petit, Blanca Salinas-Roca, Fernando Herrerías, Felip Vilardell, Mari Cruz de la Fuente, Judit Pallares, Maite Santamaría, Marta Zorzano-Martínez, Enric Sánchez, Xavier Matías-Guiu, Carolina López-Cano, Ana Gloria Soler, Josep León-Mengíbar, Marta Bueno, Albert Lecube
Journal: Obesity Facts
Obes Facts (2024) 17 (5): 473–482.
https://doi.org/10.1159/000538765
Published Online: 26 June 2024
... Lecube Introduction: Nonalcoholic fatty liver disease (NAFLD), now termed metabolic dysfunction-associated steatotic liver disease (MASLD), is an escalating health concern linked to obesity and type 2 diabetes. Despite liver biopsy being the gold standard, its invasiveness underscores the need...
View articletitled, Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver ® ) Diagnoses
Open the PDF for Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver ® ) Diagnoses in another window